Abstract:Objectives: To study the therapeutic effects of combined tamsulosin hydrochloride and terazosin treatment for patients with chronic prostatitis Type-III b. Methods: This study involved 180 patients with chronic prostatitis Type-III b treated between January 2018 and December 2020 conducted at Nanhua Hospital Affiliated to Nanhua University. Patients were randomly divided into two equal groups: one receiving oral terazosin hydrochloride tablets only (control group), and one orally receiving both tamsulosin hydrochloride sustained-release tablets and terazosin hydrochloride tablets (observation group). Outcome measurements included symptom scoring, inflammatory cytokine levels, as well as white blood cell and lecithin body counts in the prostatic fluid. Results: After 30 days of treatment, the observation group showed greater treatment effectiveness (86.67% vs. 73.33%, P<0.05). QLS, USS, PS, and NIH-CPSI symptom scores were lower in the observation group than the control group (P<0.05). No differences in adverse event distribution and incidence were noted. EPS IL-2 increased more in the observation group, while PGE-2, MIP-1α, and MIP-2 decreased more in the observation group. WBC levels decreased more in the observation group, while lecithin body levels increased more in the observation group. Conclusion: The combination of tamsulosin hydrochloride and terazosin for the treatment of patients with chronic prostatitis Type-III b has a significant effect. This approach reduced patient symptoms, lowered inflammatory biomarkers, and generally improved quality of life. This approach appears to have clinical value worthy of future investigation. doi: https://doi.org/10.12669/pjms.38.3.4931 How to cite this:Duan B, Wang X. The effectiveness of tamsulosin hydrochloride with terazosin combination therapy for chronic prostatitis Type-III b. Pak J Med Sci. 2022;38(3):---------. doi: https://doi.org/10.12669/pjms.38.3.4931 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Clinical effect of Xipayimaibizi capsules combined with tamsulosin hydrochloride sustained-release tablets on type ⅢA chronic nonbacterial prostatitis

Prostatic Calculi Influence the Antimicrobial Efficacy in Men with Chronic Bacterial Prostatitis

The effectiveness of tamsulosin hydrochloride with terazosin combination therapy for chronic prostatitis Type-III b

Effect of QianlieShutong capsule combined with tamsulosin on serum testosterone and estrogen in patients with benign prostatic hyperplasia and its efficacy

Observation on Curative Efficacy of Tamsulosin Hydrochloride Sustained-Release Capsules Combined with Finasteride Tablets in the Treatment of Benign Prostatic Hyperplasia

Clinical Observation of Comprehensive Treatment for Type Ⅲ A Prostatitis

[Clinical Observation on Therapeutic Effect of Suspended Moxibustion on Temperature-Sensitive Acupoints Plus Medication for Chronic Prostatitis].

[Efficacy of Lamiophlomis Rotata Capsule in the Treatment of Type ⅢB Prostatitis].

Pharmacoeconomic Evaluation of Tamsulosin Hydrochloride Sustained-release Capsules in the Treatment of Benign Prostatic Hyperplasia

The Efficacy of Prostatic Massage Combined with Α1 Receptor Blocker in the Treatment of Type Ⅲ Prostatitis

Effect of modified prostate massage combined with medicines for the type ofIII A prostatitis

Qianlieping Capsule plus α-blocker for chronic non-bacterial prostatitis: Analysis of 220 cases

Efficacy and safety of tolterodine for treatment of men with chronic prostatitis (typeⅢ)

Therapeutic observation of three combinationtherapies for type ⅢA chronic prostatitis

Clinical Observation of Combined Cavity Interventional Therapy and Traditional Chinese Medicineon Prostatitis Type Ⅲ

[Bushen Daozhuo Granules for type Ⅲ prostatitis: A multicenter randomized controlled clinical trial].

Clinical Observation of Azithromycin Combined with Doxazosin and Qianlieanshuan in the Treatment of NIH Ⅲ Prostatitis

[Simiaotongzhuo Decoction for the treatment of type III prostatitis: A clinical observation]

Beneficial Effect of Tamsulosin Combined with Dapoxetine in Management of Type III Prostatitis with Premature Ejaculation

Qianlieping capsule plus alpha-blocker for chronic non-bacterial prostatitis: analysis of 220 cases]

Yunnan Baiyao Capsule Combined with Compound Ciprofloxacin Suppository for NIH-Ⅲ a Prostatitis